CASTAGNOLI, RICCARDO
 Distribuzione geografica
Continente #
NA - Nord America 3.885
AS - Asia 2.811
EU - Europa 1.924
SA - Sud America 669
AF - Africa 80
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 5
Totale 9.385
Nazione #
US - Stati Uniti d'America 3.746
CN - Cina 1.037
SG - Singapore 803
IE - Irlanda 591
BR - Brasile 556
HK - Hong Kong 517
RU - Federazione Russa 351
DE - Germania 245
VN - Vietnam 166
FI - Finlandia 165
IT - Italia 139
GB - Regno Unito 101
IN - India 90
CA - Canada 88
SE - Svezia 88
UA - Ucraina 57
AR - Argentina 46
PL - Polonia 42
BD - Bangladesh 39
MX - Messico 36
NL - Olanda 31
AT - Austria 29
ZA - Sudafrica 29
JP - Giappone 25
IQ - Iraq 23
EC - Ecuador 20
ES - Italia 19
ID - Indonesia 18
FR - Francia 15
BE - Belgio 14
MA - Marocco 12
PK - Pakistan 11
AU - Australia 10
IL - Israele 10
KE - Kenya 10
CO - Colombia 9
LT - Lituania 9
TR - Turchia 9
EG - Egitto 8
GR - Grecia 8
PE - Perù 8
PY - Paraguay 8
MU - Mauritius 7
VE - Venezuela 7
AZ - Azerbaigian 6
CL - Cile 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
CH - Svizzera 5
JO - Giordania 5
SA - Arabia Saudita 5
TN - Tunisia 5
BO - Bolivia 4
EU - Europa 4
MY - Malesia 4
PA - Panama 4
UY - Uruguay 4
BG - Bulgaria 3
CR - Costa Rica 3
DZ - Algeria 3
IR - Iran 3
KG - Kirghizistan 3
KR - Corea 3
LB - Libano 3
PH - Filippine 3
AM - Armenia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
GA - Gabon 2
GE - Georgia 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
NP - Nepal 2
OM - Oman 2
RO - Romania 2
TH - Thailandia 2
AP - ???statistics.table.value.countryCode.AP??? 1
BB - Barbados 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GM - Gambi 1
GP - Guadalupe 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MZ - Mozambico 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
TT - Trinidad e Tobago 1
Totale 9.385
Città #
Dublin 585
Hong Kong 514
Chandler 492
Dallas 484
Ashburn 379
Singapore 367
Beijing 292
Boardman 163
Princeton 124
Los Angeles 123
Lawrence 120
Medford 104
Helsinki 99
Jacksonville 98
Munich 88
Nanjing 86
Redondo Beach 84
New York 83
Wilmington 75
Ho Chi Minh City 67
Buffalo 63
Shanghai 61
São Paulo 58
Moscow 54
Ann Arbor 50
Toronto 43
The Dalles 38
Chicago 37
Nuremberg 37
Seattle 37
Turku 36
Changsha 35
Warsaw 35
Nanchang 33
Hanoi 29
Shenyang 27
Washington 25
Brooklyn 24
Hangzhou 24
Tokyo 23
Jiaxing 22
Rio de Janeiro 22
Milan 21
Montreal 21
Tianjin 21
Hebei 20
Atlanta 19
Johannesburg 19
Orem 19
Denver 18
Santa Clara 18
Chennai 17
Fairfield 17
Falkenstein 16
London 16
Council Bluffs 15
San Francisco 15
Stockholm 15
Belo Horizonte 14
Boston 14
Brussels 14
Columbus 14
Dhaka 14
Phoenix 14
Mexico City 13
Pavia 13
Brasília 12
Guangzhou 12
Houston 12
Hyderabad 12
Poplar 12
Pune 12
Woodbridge 12
Norwalk 11
Redwood City 11
Des Moines 10
Mumbai 10
Vienna 10
Zhengzhou 10
Amsterdam 9
Baghdad 9
Guayaquil 9
Jinan 9
Nairobi 9
Jakarta 8
San Jose 8
Dearborn 7
Düsseldorf 7
Elk Grove Village 7
Frankfurt am Main 7
Querétaro 7
Rome 7
Shenzhen 7
Varese 7
Wuhan 7
Baku 6
Chengdu 6
Haiphong 6
Manchester 6
Melbourne 6
Totale 5.937
Nome #
A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: A three-center, assessor blinded trial 141
Clinical features of pediatric chronic urticaria: A single-center analysis 128
Impact of passive smoke and/or atopy on adenoid immunoglobulin production in children 126
Allergy work-up in a child undergoing general anesthesia, with suspected latex allergy 119
Allergic reaction to oral Furosemide 114
Amiodarone hypersensitivity reaction and basophil activation test 110
ATOPIC DERMATITIS: IS THERE A ROLE FOR PROBIOTICS? 107
Asthma endotyping and biomarkers in childhood asthma 102
Allergen immunotherapy for IgE-mediated food allergy: There is a measure in everything to a proper proportion of therapy 101
Auto-antibodies against type I IFNs in patients with life-threatening COVID-19 100
An immune-based biomarker signature is associated with mortality in COVID-19 patients. 100
From IgE to clinical trials of allergic rhinitis 99
The role of upper airway pathology as a co-morbidity in severe asthma 99
X-Linked Hypohidrotic Ectodermal Dysplasia: New Features and a Novel EDA Gene Mutation 97
Allergy and asthma in children and adolescents during the COVID outbreak: What we know and how we could prevent allergy and asthma flares 97
Additional Concerns Regarding Children With Coronavirus Disease 2019-Reply 94
Current and emerging biologic therapies for allergic rhinitis and chronic rhinosinusitis 92
Allergy and covid-19 92
Clinical and Epidemiological Features of Pediatric Patients with COVID-19 in a Tertiary Pediatric Hospital 91
An update on anti-ige therapy in pediatric respiratory diseases 91
Current recommendations and emerging options for the treatment of allergic rhinitis. 90
Eosinophilic gastrointestinal disorders in children: An Italian single-center experience 90
Omalizumab for the treatment of chronic idiopathic/spontaneous urticaria in children 88
Allergen immunotherapy in children and adolescents with respiratory diseases 88
An update on biological therapies for pediatric allergic diseases 87
Egg allergy: diagnosis and benefit of basophilic activation test 86
Biologic Use in Allergic and Asthmatic Children and Adolescents during the COVID-19 Pandemic 85
Predicting challenge outcomes in children: role of histamine levels 80
Omalizumab in children. 80
SARS-CoV-2 infection in pediatric population 79
COVID-19 and autoimmune diseases: is there a connection? 78
Association between treatment awareness and uncontrolled asthma in adolescents 78
Biomarkers of immunotherapy response in patients with allergic rhinitis 78
Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic 78
Alpha-Gal Syndrome in Children: Peculiarities of a “Tick-Borne” Allergic Disease 78
Novel biologics for the treatment of pediatric severe asthma 77
Behavioral issues and quality of life in children with eosinophilic esophagitis 77
Timely adaptation of a pediatric unit to COVID-19 emergency in Northern Italy: The experience of Fondazione IRCCS Policlinico San Matteo in Pavia 76
COVID-19 in the pediatric population admitted to a tertiary referral hospital in Northern Italy: Preliminary clinical data 76
A compilation answering 50 questions on monkeypox virus and the current monkeypox outbreak 75
An asymptomatic mediastinal cyst in a young child: Case report and summary of the literature 75
Off-label treatment with Cyclosporine A in a child with severe atopic dermatitis 74
Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19 73
An update on the role of chronic rhinosinusitis with nasal polyps as a co-morbidity in severe asthma 72
Food allergies: Current and future treatments 70
Novel Approaches to the Study of Neonatal Infections 70
Admission rates for respiratory diseases during the covid-19 pandemic: The experience of the pediatric clinic in Pavia 69
Mitochondrial Complex I Deficiency: Unraveling the Relevance of NDUFAF1 in Pediatric Hypertrophic Cardiomyopathy 69
Dupilumab to Treat Type 2 Inflammatory Diseases in Children and Adolescents 69
Protocols for drug allergy desensitization in children 67
Selective IgM Deficiency: Evidence, Controversies, and Gaps 66
Omalizumab in children with severe allergic asthma: The Italian real- life experience 66
Immunomodulation in pediatric asthma 65
Defining intestinal tissue pathology and microbiota/metabolome composition in mice carrying Rag1 hypomorphic mutations 65
Autoantibodies Against Proteins Previously Associated With Autoimmunity in Adult and Pediatric Patients With COVID-19 and Children With MIS-C 65
Eosinophilic Gastrointestinal Diseases in Inborn Errors of Immunity 64
Hymenoptera venom allergy among children in Italy: time for pediatricians to take action 64
Towards precision medicine in pediatric severe asthma: An update on current and emerging biomarkers 62
Clinical Heterogeneity of Early-Onset Autoimmune Gastritis: From the Evidence to a Pediatric Tailored Algorithm 61
Low T-Cell Receptor beta (TRB) Repertoire Diversity Early Post-Transplant for Severe Combined Immunodeficiency (SCID) Predicts Subsequent Failure of Immune Reconstitution 61
Clinical and immunological phenotypes of selective IgM deficiency in children: Results from a multicenter study 60
Drug allergy: epidemiology of a cohort of pediatric patient 60
NGS Reveals Repertoire Restriction of Treg Cells in APDS1 Patients 60
Type-2 inflammatory mediators as targets for precision medicine in children 60
Targeted Therapy for Severe Asthma in Children and Adolescents: Current and Future Perspectives 59
Quantitation of T Cell Repertoire Diversity Following Treatment for SCID 59
Personalized therapies for the treatment of allergic rhinitis 58
Pediatric COVID-19 – a review 58
Characterization of Gut Inflammation and Autoimmunity in Mice Carrying Rag1 Hypomorphic Mutations 57
Skin tests are important in children with β-lactam hypersensitivity, but may be reduced in number 56
Inborn errors of immunity with atopic phenotypes in the allergy and immunology clinic: a practical review 56
Immunological basis of virus-host interaction in COVID-19 55
Activated phosphoinositide 3-dinase delta syndrome (APDS): An update 55
Pediatric COVID-19 – a review 54
The use of basophil activation test to diagnose egg-allergy in children 54
Complete Absence of CD3γ Protein Expression Is Responsible for Combined Immunodeficiency with Autoimmunity Rather than SCID 54
Low T-cell receptor beta (TRB) Repertoire Diversity Early Post-transplant for Severe Combined Immunodeficiency SCID Predicts Subsequent Failure of Immune Reconstitution 53
Updates on new monogenic inborn errors of immunity 53
Human inborn errors of immunity caused by defects of receptor and proteins of cellular membrane 52
Low T-Cell Receptor β ( ) Repertoire Diversity Early Post-Transplant for Severe Combined Immunodeficiency (SCID) Predicts Subsequent Failure of Immune Reconstitution 52
Monoclonal antibodies in pediatric allergy 51
Development of a peptide conjugate vaccine for inducing therapeutic anti-IgE antibodies 51
New approaches for identifying and testing potential new anti-asthma agents 51
Anxiety and depression in adolescents with asthma: a study in clinical practice 51
The discovery and development of omalizumab for the treatment of asthma 50
Eosinophilic esophagitis after congenital diaphragmatic hernia 50
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents: A Systematic Review 50
Urticaria in childhood 50
Comprehensive genetic results for primary immunodeficiency disorders in a highly consanguineous population 50
CAR-T Cell Therapy in Autoimmune Setting: A New Appealing Approach Extendable to Allergy? 47
Clinical Manifestations and Treatment Response of Patients With Syndrome of Undifferentiated Recurrent Fever (SURF) 47
Tryptase and histamine may support oral food challenge in the diagnosis of allergy 47
The Nose and the Lung: United Airway Disease? 47
Severe uncontrolled asthma in children: Practical approach on diagnosis and management 47
Inadequate literacy is associated with uncontrolled asthma in adolescents 47
Emerging drugs for the treatment of perennial allergic rhinitis 46
Identification of gut inflammation and autoimmunity in murine models carrying Rag1 hypomorphic mutations 46
Soluble CD13 is a potential mediator of neutrophil-induced thrombogenic inflammation in SARS-CoV-2 infection 45
High throughput sequencing reveals repertoire restriction of Treg and CD8(+) T cells in APDS1 patients 45
Applying the new guidelines to asthma management in children 45
Totale 7.159
Categoria #
all - tutte 53.384
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.384


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021190 0 0 0 0 0 52 14 55 8 36 20 5
2021/2022616 13 2 30 3 17 44 4 15 33 96 75 284
2022/20231.529 176 104 32 107 95 152 1 84 696 6 59 17
2023/2024776 76 140 52 45 64 192 48 44 6 51 38 20
2024/20252.478 36 185 57 64 49 91 220 120 577 121 351 607
2025/20263.383 517 459 729 673 765 240 0 0 0 0 0 0
Totale 9.613